Literature DB >> 25143870

G protein signaling modulator-3: a leukocyte regulator of inflammation in health and disease.

Matthew J Billard1, Bryan J Gall2, Kristy L Richards3, David P Siderovski2, Teresa K Tarrant4.   

Abstract

G protein signaling modulator-3 (GPSM3), also known as G18 or AGS4, is a member of a family of proteins containing one or more copies of a small regulatory motif known as the GoLoco (or GPR) motif. GPSM3 interacts directly with Gα and Gβ subunits of heterotrimeric G proteins to regulate downstream intracellular signals initiated by G protein coupled receptors (GPCRs) that are activated via binding to their cognate ligands. GPSM3 has a selective tissue distribution and is highly expressed in immune system cells; genome-wide association studies (GWAS) have recently revealed that single nucleotide polymorphisms (SNPs) in GPSM3 are associated with chronic inflammatory diseases. This review highlights the current knowledge of GPSM3 function in normal and pathologic immune-mediated conditions.

Entities:  

Keywords:  G protein coupled receptor; GPSM3; GoLoco; chemokine; migration; rheumatoid arthritis

Year:  2014        PMID: 25143870      PMCID: PMC4138133     

Source DB:  PubMed          Journal:  Am J Clin Exp Immunol


  59 in total

Review 1.  Myeloid-derived suppressor cells in cancer patients: a clinical perspective.

Authors:  Alberto J Montero; Claudia Marcela Diaz-Montero; Christos E Kyriakopoulos; Vincenzo Bronte; Susanna Mandruzzato
Journal:  J Immunother       Date:  2012 Feb-Mar       Impact factor: 4.456

Review 2.  How many drug targets are there?

Authors:  John P Overington; Bissan Al-Lazikani; Andrew L Hopkins
Journal:  Nat Rev Drug Discov       Date:  2006-12       Impact factor: 84.694

3.  RGS molecule expression in murine B lymphocytes and ability to down-regulate chemotaxis to lymphoid chemokines.

Authors:  K Reif; J G Cyster
Journal:  J Immunol       Date:  2000-05-01       Impact factor: 5.422

4.  Receptor-independent activators of heterotrimeric G-protein signaling pathways.

Authors:  A Takesono; M J Cismowski; C Ribas; M Bernard; P Chung; S Hazard; E Duzic; S M Lanier
Journal:  J Biol Chem       Date:  1999-11-19       Impact factor: 5.157

Review 5.  The 7 TM G-protein-coupled receptor target family.

Authors:  Edgar Jacoby; Rochdi Bouhelal; Marc Gerspacher; Klaus Seuwen
Journal:  ChemMedChem       Date:  2006-08       Impact factor: 3.466

6.  CCR5 blockade in rheumatoid arthritis: a randomised, double-blind, placebo-controlled clinical trial.

Authors:  Arno W R van Kuijk; Clarissa E Vergunst; Danielle M Gerlag; Barry Bresnihan; Juan J Gomez-Reino; Regine Rouzier; Patrick C Verschueren; Christiaan van der Leij; Christiaan van de Leij; Mario Maas; Maarten C Kraan; Paul P Tak
Journal:  Ann Rheum Dis       Date:  2010-08-06       Impact factor: 19.103

Review 7.  Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients.

Authors:  Takuji Iwamoto; Hiroshi Okamoto; Yoshiaki Toyama; Shigeki Momohara
Journal:  FEBS J       Date:  2008-07-24       Impact factor: 5.542

8.  The proline-rich N-terminal domain of G18 exhibits a novel G protein regulatory function.

Authors:  Peishen Zhao; Chau H Nguyen; Peter Chidiac
Journal:  J Biol Chem       Date:  2010-01-22       Impact factor: 5.157

9.  G-protein signaling modulator-3 regulates heterotrimeric G-protein dynamics through dual association with Gβ and Gαi protein subunits.

Authors:  Patrick M Giguère; Geneviève Laroche; Emily A Oestreich; David P Siderovski
Journal:  J Biol Chem       Date:  2011-12-13       Impact factor: 5.157

10.  Rituximab is more effective than second anti-TNF therapy in rheumatoid arthritis patients and previous TNFα blocker failure.

Authors:  Joern Kekow; Ulf Mueller-Ladner; Hendrik Schulze-Koops
Journal:  Biologics       Date:  2012-07-02
View more
  13 in total

1.  Regulation of Chemokine Signal Integration by Activator of G-Protein Signaling 4 (AGS4).

Authors:  William G Robichaux; Melissa Branham-O'Connor; Il-Young Hwang; Ali Vural; Johne H Kehrl; Joe B Blumer
Journal:  J Pharmacol Exp Ther       Date:  2017-01-06       Impact factor: 4.030

Review 2.  G protein coupled receptors signaling pathways implicate in inflammatory and immune response of rheumatoid arthritis.

Authors:  Jinling Shu; Feng Zhang; Lingling Zhang; Wei Wei
Journal:  Inflamm Res       Date:  2016-11-23       Impact factor: 4.575

3.  RNA Sequencing Reveals Distinct Immune Responses in the Chorioamniotic Membranes of Women with Preterm Labor and Microbial or Sterile Intra-amniotic Inflammation.

Authors:  Kenichiro Motomura; Roberto Romero; Jose Galaz; Adi L Tarca; Bogdan Done; Yi Xu; Yaozhu Leng; Valeria Garcia-Flores; Marcia Arenas-Hernandez; Kevin R Theis; Meyer Gershater; Eunjung Jung; Chaur-Dong Hsu; Nardhy Gomez-Lopez
Journal:  Infect Immun       Date:  2021-04-16       Impact factor: 3.441

4.  Localization and expression profile of Group I and II Activators of G-protein Signaling in the kidney.

Authors:  Marek Lenarczyk; Jeffrey D Pressly; Joanna Arnett; Kevin R Regner; Frank Park
Journal:  J Mol Histol       Date:  2014-12-23       Impact factor: 2.611

5.  RNA Sequencing Reveals Diverse Functions of Amniotic Fluid Neutrophils and Monocytes/Macrophages in Intra-Amniotic Infection.

Authors:  Nardhy Gomez-Lopez; Roberto Romero; Aneesha Varrey; Yaozhu Leng; Derek Miller; Bogdan Done; Yi Xu; Gaurav Bhatti; Kenichiro Motomura; Meyer Gershater; Roger Pique-Regi; Adi L Tarca
Journal:  J Innate Immun       Date:  2020-11-05       Impact factor: 7.349

6.  Fluorescence polarization assays to measure interactions between Gα subunits of heterotrimeric G proteins and regulatory motifs.

Authors:  Marcin Maziarz; Mikel Garcia-Marcos
Journal:  Methods Cell Biol       Date:  2017-09-11       Impact factor: 1.441

Review 7.  The impact of RGS and other G-protein regulatory proteins on Gαi-mediated signaling in immunity.

Authors:  John H Kehrl
Journal:  Biochem Pharmacol       Date:  2016-04-09       Impact factor: 5.858

8.  Reduction of GPSM3 expression akin to the arthritis-protective SNP rs204989 differentially affects migration in a neutrophil model.

Authors:  B J Gall; A B Schroer; J D Gross; V Setola; D P Siderovski
Journal:  Genes Immun       Date:  2016-06-16       Impact factor: 2.676

9.  Genetic variations in GPSM3 associated with protection from rheumatoid arthritis affect its transcript abundance.

Authors:  B J Gall; A Wilson; A B Schroer; J D Gross; P Stoilov; V Setola; C M Watkins; D P Siderovski
Journal:  Genes Immun       Date:  2016-01-28       Impact factor: 2.676

10.  The Succinate Receptor GPR91 Is Involved in Pressure Overload-Induced Ventricular Hypertrophy.

Authors:  Lei Yang; Di Yu; Ran Mo; Jiru Zhang; Hu Hua; Liang Hu; Yu Feng; Song Wang; Wei-Yan Zhang; Ning Yin; Xu-Ming Mo
Journal:  PLoS One       Date:  2016-01-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.